News
Cell type expertise that moves manufacturing forward.
We’ve mastered the intricate and interrelated processes required to ensure your cells function as intended as you scale faster.

GMP cell manufacturing optimized for every cell type.
We have benchmark industry experience taking an iPSC and successfully differentiating it into your targeted cell type, ensuring that new iPSC cells generated at scale look and behave exactly as intended. It’s the kind of undertaking that requires peerless capabilities in process design and optimization, analytical development, quality control and assurance, and product release.
No matter your desired cell function, our customizable offering supports the development path you need to efficiently move your medicine forward.
Accelerate speed to clinic
With Echo™, our pre-established, iPSC-based GMP manufacturing platform
Reduce process & analytical development challenges
With pre-built platform and ready-to-use starting materials (including our Allo Chassis™ or unedited master cell banks)
Secure clear IP positioning and licensing framework
With Allo Chassis™, STAR-CRISPR™, and a strong Cellistic patent estate that safeguards methods, edits, and manufacturing
Ensure regulatory readiness & GMP compliance
With our GMP platform and EMA-certified, FDA and PMDA-compliant manufacturing facility
Priming your cell therapy program to fulfill its full potential.
We’ve put our expertise in iPSCs into action by creating platforms and enabling technologies that leverage the “80/20 rule.” With a manufacturing process that uses largely pre-built components, we not only streamline operations — we sharpen our focus on the distinct details of your cell therapy that matter most.
Echo™-NK
A plug-and-play, high-yield platform for iPSC-NK manufacturing built to deliver a strategic advantage through lower COGs, broader patient access, and greater investor confidence.
Echo™-Cardio
An industrialized, end-to-end GMP manufacturing platform that delivers clinical grade, high-purity iPSC-derived cardiomyocytes at therapeutic scale, accelerating your path to the clinic.
Echo™-Endothelial
Overcomes notoriously hard scaling challenges that max out at 30% purity to deliver ~90% lineage specificity and a fully GMP-ready workflow.
Echo™-TCell
Echo™-TCell unlocks the potential of allogeneic T-cell therapies – including α/β T cells and Tregs – by generating engineered iPSC-T cells designed for potency, persistence, and safety at scale.
See how we're leading cell therapy manufacturing.
View all
Easier said than done? Let’s see.
Start with a cell. Expand it. Differentiate it. Expand it again — with no changes from beginning to end. Four seemingly simple steps that come with a nearly endless cascade of decisions that can make the difference between success and failure. We’ve mastered those steps. Let’s talk about how you can use that experience to your advantage.